Altrinsic Global Advisors’s Voyager Therapeutics VYGR Stock Holding History

Altrinsic Global Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-40,000	Closed	-$505K	–	91
2020 Q2	$505K	Sell	40,000 -10,000	-20%	-$116K	0.02%	79
2020 Q1	$458K	Buy	+50,000	New	+$574K	0.03%	72
2019 Q3	–	Sell	-50,000	Closed	-$1.36M	–	79
2019 Q2	$1.36M	Sell	50,000 -139,927	-74%	-$3.2M	0.06%	69
2019 Q1	$3.63M	Hold	189,927	–	–	0.17%	48
2018 Q4	$1.78M	Buy	189,927 +10,000	+6%	+$128K	0.09%	58
2018 Q3	$3.4M	Buy	179,927 +5,000	+3%	+$95.9K	0.15%	51
2018 Q2	$3.42M	Hold	174,927	–	–	0.14%	59
2018 Q1	$3.29M	Sell	174,927 -90,000	-34%	-$1.95M	0.13%	56
2017 Q4	$4.4M	Buy	264,927 +100,000	+61%	+$1.71M	0.17%	51
2017 Q3	$3.4M	Sell	164,927 -15,073	-8%	-$170K	0.13%	61
2017 Q2	$1.61M	Buy	180,000 +70,000	+64%	+$705K	0.06%	70
2017 Q1	$1.46M	Buy	110,000 +10,000	+10%	+$121K	0.05%	72
2016 Q4	$1.27M	Buy	+100,000	New	+$1.28M	0.05%	73

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altrinsic Global Advisors's VYGR Position: Q3 2020 in Review

Altrinsic Global Advisors sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 40,000 shares — an estimated $505K sold.

Altrinsic Global Advisors first reported a position in VYGR in Q4 2016 and held it in 13 quarters. The position peaked at $4.4M in Q4 2017. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

Altrinsic Global Advisors reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
Altrinsic Global Advisors sold 40,000 Voyager Therapeutics shares in Q3 2020, an estimated $505K.
Altrinsic Global Advisors first reported a position in Voyager Therapeutics in Q4 2016 and held it in 13 quarters.
Altrinsic Global Advisors's Voyager Therapeutics position peaked at $4.4M in Q4 2017.
110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Altrinsic Global Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.